Skip to main content
Premium Trial:

Request an Annual Quote

New Products Posted to GenomeWeb: Biodesix, Curio Genomics, Akoya Biosciences, More

Biodesix GeneStrat NGS

Biodesix has launched GeneStrat NGS, a 52-gene blood-based tumor profiling test intended to help physicians treating advanced-stage lung cancer patients identify targeted therapy mutations, such as EGFR, ALK, KRAS, MET, NTRK, ERBB2, and others. Sequencing results are further interrogated using PierianDx's variant interpretation knowledge database. Physicians receive a streamlined report with a 72-hour turnaround time.

GeneStrat NGS is also a component of a broader test package that Biodesix also recently launched, the IQLung Treatment Guidance Testing Strategy, which includes blood-based proteomic and genomic testing workflows. The company said it plans to add tests to the IQLung portfolio in the future.


Curio Genomics/Daicel Arbor Biosciences MyCurio Bioinformatics Platform

Curio Genomics and Daicel Arbor Biosciences have launched the cloud-based bioinformatics platform myCurio, which resulted from a multi-year partnership between the firms. The platform consists of three modules. MyCurio Reports lets researchers review and visualize genome reference alignment, coverage, and variant calls for each sample; myCurio Insights enables them to interpret their complete dataset; and myCurio PowerTools provides bioinformaticians with configuration capabilities to optimize analyses.


Akoya Biosciences PhenoCycler-Fusion System

Akoya Biosciences has launched the PhenoCycler-Fusion system for high-speed imaging of slides at single-cell and sub-cellular resolution. The platform combines the strengths of the firm's automated, high-multiplex cycling platform PhenoCycler (previously branded as Codex) and its high-speed imaging platform PhenoImager (previously branded as Phenoptics) into an integrated workflow. In addition to protein biomarkers, the system can detect RNA, using RNAScope assays developed in collaboration with Bio-Techne. It can detect more than 100 markers for deep spatial phenotyping and map every cell across a tissue section, including from FFPE slides. It is capable of processing more than 100 slides per week, according to the company.


For more new products and services, please visit the New Products page on our website.

The Scan

Call for a Different Tack

Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News.

Wastewater Warning

The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge.

Can't Get in the Program

Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports.

Science Paper on Spatial-Controlled Genome Editing

In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.